bioRxivPhysiologyPreprint
Soluble and insoluble dietary fibres differentially affect liver steatosis and gut microbiota in western-diet fed mice
Céline Marie Pauline Martin, Mathilde Miquel, Valérie Alquier‐BacquieiD, Arnaud PolizziiD, Frédéric Lasserre, Marine HuilletiD, Clémence Rives, Justine BruseiD, Julie Jarrasier, Prunelle PerrieriD, Joana GomesiD, Claire Naylies, Charlène J. G. DauriatiD, Nancy Geoffre, Anaelle DurbeciD, Adeline Duchampt, Alain Thirault, Xavier Blanc, Elodie Rousseau-BacquiéiD, Yannick LippiiD, Justine Bertrand‐MicheliD, Cécile CanletiD, Benoît ChassaingiD, Anne FougeratiD, Laurence Gamet‐PayrastreiD, , Sandrine Ellero‐SimatosiD
Abstract
ScopeMetabolic dysfunction-associated steatotic liver disease (MASLD) is the most common chronic hepatic liver disease. An imbalance diet, rich in lipids and sugars and low in fibre, is a key contributing factor. However, there is limited knowledge about how soluble and fermentable dietary fibres, compared to insoluble and non-fermentable fibres, differently affect liver metabolism through their interactions with the intestinal microbiota. Methods and resultsMale mice housed at thermoneutrality were fed a Western Diet (WD) supplemented with fermentable inulin or non-fermentable cellulose for 18 weeks. Inulin supplementation mitigated WD-induced obesity, glucose intolerance, dyslipidemia and protected against WD-induced hepatic steatosis compared to cellulose. Hepatic gene expression changes induced by WD were attenuated with inulin. Additionally, inulin preserved gut microbiota composition and metabolism, indicating greater resilience against diet-induced perturbations. ConclusionThese findings suggest that soluble dietary fibres like inulin confer superior metabolic and hepatic benefits over insoluble fibres by modulating the gut microbiota-liver axis, highlighting their potential role in MASLD management.
- organism: mouse
- assay: bulk RNA-seq
- research focus: host-pathogen & immune response
- research focus: metabolism & bioenergetics
- research focus: cell type annotation
- approach: experimental assay
- Citations
- 0
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Gut microbes mediate the synergistic effects of dietary cholesterol and saturated fat in driving fibrosing MASH
Jake B. Hermanson, Samar A. Tolba, … Vanessa Leone·Gut MicrobesPeer-reviewed·May 10, 2026
- Totum-448, a polyphenol-rich plant extract, decreases hepatic steatosis and inflammation in diet-induced MASLD mice
Joost M. Lambooij, Vivien Chavanelle, … Bruno Guigas·npj gut and liver.Peer-reviewed·Sep 3, 2025
- Prebiotic xylo-oligosaccharides for alleviation of hepatic steatosis: Results from a four-month dietary intervention and determinants of response
Jukka E. Hintikka, Perttu Permi, … Satu Pekkala·npj gut and liver.Peer-reviewed·May 6, 2026
- Oral supplementation of gut microbial metabolite indole-3-acetate alleviates diet-induced steatosis and inflammation in mice
Y. Ding, K. Yanagi, … A. Jayaraman·bioRxiv·Mar 21, 2023
- Liraglutide exerts protective effects on MASLD independently of lipophagy, and the combination with kombucha presents no additional advantage
Jenifer Souza de Almeida, Sandra Andreotti, … Carla Roberta de Oliveira Carvalho·Brazilian Journal of Health ReviewPeer-reviewed·Jan 19, 2026
- Gut microbial phenylalanine metabolism contributes to MASLD in a dietary protein-dependent manner
Yi Rou Bah, Dayang Nurul Asyiqin Binte Mustafa, … Kazuyuki Kasahara·bioRxiv·Sep 28, 2026